Cell Therapy Market size is projected to grow USD 23.9 billion by 2030

The Market Statsville Group (MSG) publishes the new report on the "Cell Therapy Market by Use-Type (Clinical-use (Therapeutic Area and Cell Type) and Research-use), by Therapy Type (Allogenic Therapies and Autologous Therapies), by Region - Global Share and Forecast to 2030". The global cell therapy market size is projected to grow USD 23.9 billion by 2030 from USD 8.1 billion in 2021, registering a CAGR of 14.5% during the forecast period. Market growth has been aided by the gradual emergence of new technologies to support the development of advanced cellular therapies. The introduction of proprietary cell lines is recognized as the primary means by which a single product can be exploited to produce a robust portfolio of candidates.

Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/cell-therapy-market

For Instance, To advance their immuno-oncology product line, a cell-based therapy developer, uses CAR-T (Chimeric Antigen Receptor T) cell expansion, dendritic cell neoantigen presentation technology, and T-cell primers. These technologies offer low-risk investments. Companies are leveraging new technologies to assist their product development activities in expanding their product portfolio and establishing out-licensing or co-development relationships with other entities. For instance, MaxCyte has over 40 high-value cell therapy partnership programs within immune-oncology, regenerative medicine, and gene editing, including 15 clinical-stage programs.

Global Cell Therapy Market Segmentation
The overall cell therapy market has been segmented into the use-type, therapy, and region.

By Use-Type Outlook (Sales/Revenue, USD Billion, 2017-2030)

Clinical-use
Therapeutic Area
Malignancies
Musculoskeletal Disorders
Autoimmune Disorders
Dermatology
Others
Cell Type
Stem Cell Therapies
BM, Blood, & Umbilical cord-derived Stem Cells
Adipose-derived cells
Others
Non-stem Cell Therapies
Research-use
By Therapy Type Outlook (Sales/Revenue, USD Billion, 2017-2030)

Allogenic Therapies
Autologous Therapies
By Region Outlook (Sales/Revenue, USD Billion, 2017-2030)

Direct Purchase Report: https://www.marketstatsville.com/buy-now/cell-therapy-market?opt=2950

North America (US, Canada, Mexico)
South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)
Autologous therapies, by therapy type, is estimated to hold the largest market share during the forecast period

Based on therapy type, the global cell therapy market is segmented into allogeneic therapies and autologous therapies. The autologous therapies segment generated the highest revenue of 55.1% of the global cell therapy market in 2021. The autologous stem cell transplant therapies segment is anticipated to grow at the fastest CAGR during the forecast period. This can be attributed to numerous advantages associated with autologous transplants. Various advantages include use of own cells, easy availability, lower risk of life-threatening complications, no need to identify an HLA-matched donor, no risk of GVHD, no need for immunosuppressive therapy, graft failure occurs rarely, mortality is lower than 5% in most studies, and elderly patients can tolerate treatment relatively well. Moreover, autologous therapies are affordable when compared to allogeneic therapies. In addition, the high survival rate associated with this transplant type as well as the relatively high adoption rate are factors expected to boost the segment growth over the forecast period.

Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/cell-therapy-market

North America accounts for the largest market share in cell therapy market

Based on the regions, the global cell therapy market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 45.2% in the global cell therapy market and was anticipated to maintain its dominance throughout the forecast period. Major factors that can be attributed to the largest share of this region are the substantial number of centers and institutes engaged in R&D pertaining to stem cell therapy. Out of the eight leading universities that support stem cell therapy throughout the world, five are U.S.-based institutes, including Harvard Stem Cell Institute, Harvard University; Yale Stem Cell Center, Yale University; The Broad Stem Cell Research Center, University of California (UCLA); Institute for Stem Cell Biology and Regenerative Medicine, Stanford University; and Cambridge Stem Cell Institute, Cambridge University. These institutes are most likely to drive stem cell research in North American countries in the coming years. Moreover, investments made by the federal bodies for expanding stem cell therapy research in the region are projected to aid in the development of the North America market of stem cell therapy.

Browse complete report: https://www.marketstatsville.com/cell-therapy-market

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the cell therapy market. It also consists of the profiles of leading companies such as JCR Pharmaceuticals Co., Ltd., Castle Creek Biosciences, Inc., MEDIPOST, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., Anterogen Co., Ltd., NuVasive, Inc., Vericel Corporation, PHARMICELL Co., Ltd, Tameika Cell Technologies, Inc., Cells for Cells, and Celgene Corporation. These market players have focused on acquisitions and expansion to gain a larger market share in the cell therapy market.

Related Reports:

Lysosomal Storage Disease Treatment Market - https://www.marketstatsville.com/lysosomal-storage-disease-treatment-market

Metagenomics Sequencing Market - https://www.marketstatsville.com/metagenomics-sequencing-market

Homeopathy and Homeopathic Medicines Market - https://www.marketstatsville.com/homeopathy-and-homeopathic-medicines-market

Contact US:
Eric Martin
800 Third Avenue Suite A #1519
New York, NY 10022
+1 (646) 663-5829 | India: +91-702-496-8807
Email: sales@marketstatsville.com
MSG Blog https://marketstatsvilleblogs.com/
Web: https://marketstatsville.com/

About US:
Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG initiated its work in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services.
We the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact.

This release was published on openPR.